Hepabert Tablet

Introduction

Hepabert is a prescription medication that contains two active ingredients: L-Ornithine L-Aspartate and Silymarin. It is available in tablet form and is commonly prescribed by healthcare professionals for various conditions.

Uses

Hepabert is primarily used to support liver function and promote liver health. It is often prescribed for individuals with liver damage or liver diseases, such as hepatitis, fatty liver disease, and cirrhosis. This medication may also be recommended for individuals who have undergone liver surgery or have experienced liver-related complications.

Dosage and Administration

The dosage of Hepabert may vary depending on the individual’s condition and response to treatment. Follow the instructions provided by your healthcare professional. Generally, the recommended dosage for adults is one tablet taken twice daily. It is best to take the tablet with or after meals to minimize the chances of stomach discomfort.

Mechanism of Action

L-Ornithine L-Aspartate in Hepabert helps in detoxifying ammonia, a waste product produced during protein metabolism, and plays a crucial role in liver health. Silymarin, the other active ingredient, is a natural antioxidant that protects liver cells from damage by harmful substances. Together, these ingredients work synergistically to support liver function and enhance its ability to regenerate.

Side Effects

Common side effects may include mild gastrointestinal symptoms such as nausea, stomach discomfort, or diarrhea. These side effects are usually temporary and resolve on their own without any specific treatment.

Serious side effects are rare but can occur. If you experience any severe or persistent side effects, such as allergic reactions, dizziness, or difficulty breathing, seek immediate medical attention.

Drug Interactions

Hepabert may interact with certain medications, supplements, or substances, potentially affecting its efficacy or leading to unwanted side effects. Inform your healthcare professional about all the medications and supplements you are currently taking, including over-the-counter drugs.

Some common drug interactions may include interactions with certain antibiotics, antifungal medications, or medications used to treat high blood pressure. Consult with your healthcare professional before starting or stopping any medications while taking Hepabert.

Precautions

Before taking Hepabert, inform your healthcare professional about any existing medical conditions, allergies, or previous adverse reactions to medications. This medication may not be suitable for individuals with severe liver impairment or hypersensitivity to any of its ingredients.

Additionally, avoid consuming alcohol while taking Hepabert, as alcohol can further damage the liver and reduce the efficacy of the medication. It is always best to consult with your healthcare professional for personalized advice based on your specific medical history.

Storage

Patient Tips

• Take Hepabert as prescribed by your healthcare professional. Do not alter the dosage or stop taking the medication without consulting with your healthcare professional.
• If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• If you have any concerns or questions about Hepabert or its use, do not hesitate to reach out to your healthcare professional for clarification and guidance.
• Follow a healthy lifestyle that includes a balanced diet, regular exercise, and avoiding excessive alcohol consumption to support liver health alongside the medication.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Low blood sugar (hypoglycaemia) (NHS UK) [Accessed 3 Jun. 2024] (online) Available at:
• Numeta G13%E Preterm, emulsion for infusion (Health Professionals SmPC) Available at:
• Hepa-Merz (International database) (Drugs.com) [Accessed 21 Jun. 2024] (online) Available at:
• OTC gene (MedlinePlus) [Accessed 4 Jun. 2024] (online) Available at:
• Jain A, Sharma BC, Mahajan B, Srivastava S, Kumar A, Sachdeva S, Sonika U, Dalal A. L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial. Hepatology. 2022 May;75(5):1194-1203. doi: 10.1002/hep.32255. Epub 2021 Dec 21. [Accessed 13 Jun. 2024] Available at: